SEC Form 4 · accession 0001123292-26-001312
Tevogen Inc. · TVGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kirti Desai
Officer — Chief Financial Officer
Period of report
Sep 14, 2026
Accepted (ET)
Sep 16, 2026 · 7:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001860871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 14, 2026 | A | 750,000 | $0.00 | A | 992,983 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock under the Tevogen Inc. (the "Company") 2024 Omnibus Incentive Plan, which will vest only upon written certification by the Company's Board of Directors that the Company has achieved $1.0 billion in aggregate revenue during the period from September 14, 2026 through September 30, 2031 (the "Performance Period"). The shares will automatically be forfeited in the event such revenue threshold is not met during Performance Period, upon termination of the Reporting Person's service with the Company for any reason, if it is determined that the Reporting Person has engaged in certain misconduct or competitive activities with the Company, in the event of transfer or attempted transfer prior to vesting, or if the award is not assumed in connection with a change in control.